Thoracic Surgery Outcomes Research Network (ThORN) Consensus Document on Defining a High-Quality Wedge Resection for Early-Stage Lung Cancer

Funding

The authors have no funding sources to disclose. Mara Antonoff reports a relationship with AstraZeneca Pharmaceuticals LP that includes: consulting or advisory; with Merck & Co Inc that includes: consulting or advisory; and with Ethicon Endo-Surgery Inc that includes: consulting or advisory. Leah Backhus reports a relationship with Roche that includes: speaking and lecture fees; with AstraZeneca Pharmaceuticals LP that includes: speaking and lecture fees; and with Johnson and Johnson SA that includes: speaking and lecture fees. Biniam Kidane reports a relationship with AstraZeneca Pharmaceuticals LP that includes: speaking and lecture fees; with Bristol-Myers Squibb Co that includes: speaking and lecture fees; with Merck & Co Inc that includes: speaking and lecture fees; with Roche that includes: speaking and lecture fees; with Olympus Corporation that includes: consulting or advisory; and with Medtronic that includes: funding grants. Robert A. Meguid reports a relationship with Medtronic that includes: consulting or advisory. Seth Krantz reports a relationship with Medtronic that includes: consulting or advisory; and with Intuitive Surgical Inc that includes: funding grants. Elliot L. Servais reports a relationship with Intuitive Surgical Inc that includes: consulting or advisory, speaking and lecture fees, and travel reimbursement. Coauthors Mara Antonoff and Brian Mitzman are senior editors for The Annals of Thoracic Surgery, and Kathryn Engelhardt is an associate editor for The Annals of Thoracic Surgery. Leah Backus and David Cooke are Directors-at-Large for The Society of Thoracic Surgeons. The other authors have no conflicts of interest to disclose.